| scholarly article | Q13442814 |
| P2093 | author name string | M Oshima | |
| K Nagashima | |||
| A Rein | |||
| J Mirro | |||
| D Muriaux | |||
| S J Rulli | |||
| J G Baumann | |||
| P2860 | cites work | In defense of the cell: TRIM5alpha interception of mammalian retroviruses | Q24561978 |
| Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 | Q24609814 | ||
| Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid | Q27734262 | ||
| Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line | Q29547239 | ||
| The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys | Q29547689 | ||
| Functional characterization of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting | Q33193191 | ||
| Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus. | Q33911943 | ||
| Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo. | Q34035941 | ||
| Reversal by dithiothreitol treatment of the block in murine leukemia virus maturation induced by disulfide cross-linking | Q34347815 | ||
| Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. | Q34350205 | ||
| Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication | Q34364648 | ||
| A conserved mechanism of retrovirus restriction in mammals | Q35422974 | ||
| Effects of blocking individual maturation cleavages in murine leukemia virus gag. | Q35542805 | ||
| Synthesis and circularization of N- and B-tropic retroviral DNA Fv-1 permissive and restrictive mouse cells | Q36390971 | ||
| Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. | Q36624411 | ||
| Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. | Q36650046 | ||
| Maturation of dimeric viral RNA of Moloney murine leukemia virus. | Q36652049 | ||
| Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants Containing Cores with Abnormally High Levels of Capsid Protein and Virtually No Reverse Transcriptase | Q37060306 | ||
| mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers | Q37568355 | ||
| High-resolution structure of a retroviral capsid hexameric amino-terminal domain | Q39272732 | ||
| Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly | Q39777412 | ||
| Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes | Q40972930 | ||
| Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly | Q41047831 | ||
| Use of retroviral vectors for gene transfer and expression | Q41582824 | ||
| Image reconstructions of helical assemblies of the HIV-1 CA protein | Q41631451 | ||
| A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection | Q42798292 | ||
| HIV-1 capsid mutants inhibit the replication of wild-type virus at both early and late infection phases | Q45759776 | ||
| HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus | Q45843803 | ||
| Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses | Q46555479 | ||
| Assembly and analysis of conical models for the HIV-1 core. | Q52228420 | ||
| Structure of the amino-terminal core domain of the HIV-1 capsid protein | Q71142552 | ||
| Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication | Q73514585 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virion | Q1757347 |
| leukemia | Q29496 | ||
| murine leukemia virus | Q673848 | ||
| infectivity | Q1662346 | ||
| P304 | page(s) | 364-371 | |
| P577 | publication date | 2006-01-19 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. | |
| P478 | volume | 347 |
| Q41730903 | A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro |
| Q35750243 | A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein |
| Q34771244 | A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid |
| Q42546287 | A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle |
| Q33887851 | An immature retroviral RNA genome resembles a kinetically trapped intermediate state |
| Q33619173 | Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag |
| Q36673166 | Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly. |
| Q34320638 | Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome. |
| Q92623235 | Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes |
| Q37430541 | Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins |
| Q34237075 | Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications |
| Q35635221 | Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein. |
| Q37447762 | HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. |
| Q94322236 | IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag |
| Q36748014 | Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses |
| Q35477673 | Lentiviral Gag assembly analyzed through the functional characterization of chimeric simian immunodeficiency viruses expressing different domains of the feline immunodeficiency virus capsid protein |
| Q40174170 | Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein |
| Q28729128 | Studies on the restriction of murine leukemia viruses by mouse APOBEC3 |
| Q36958798 | Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation |
| Q27009643 | The choreography of HIV-1 proteolytic processing and virion assembly |
| Q39969339 | The incorporation of APOBEC3 proteins into murine leukemia viruses |
| Q36614059 | The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability |
| Q39156517 | The retrovirus MA and PreTM proteins follow immature MLV cores |
| Q38044517 | Virus assembly and plasma membrane domains: which came first? |
Search more.